Rockville, MD, United States of America

Suddhasil Mookherjee


 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Suddhasil Mookherjee: Innovator in Gene Therapy

Introduction

Suddhasil Mookherjee is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of inherited retinal diseases. With a total of 3 patents, his work focuses on innovative methods to improve visual function in patients suffering from specific eye conditions.

Latest Patents

Mookherjee's latest patents include groundbreaking methods and compositions for treating Leber congenital amaurosis. This involves the use of expression vectors, viral particles, and therapeutic methods aimed at enhancing the visual function of patients affected by this condition. His work specifically addresses the failure to produce a particular protein in the eye or the production of a non-functional protein, particularly in cases of Leber Congenital Amaurosis (LCA) and CEP290-related LCA. Another notable patent involves RP2 and RPGR vectors for treating X-linked retinitis pigmentosa. This patent discloses adeno-associated virus (AAV) vectors that comprise a nucleotide sequence encoding RP2 or RPGR-ORF15, along with related pharmaceutical compositions. The methods outlined in this patent aim to treat or prevent X-linked retinitis pigmentosa, increase photoreceptor numbers in the retina of mammals, and enhance visual acuity.

Career Highlights

Throughout his career, Mookherjee has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His research has significantly advanced the understanding and treatment of genetic eye disorders.

Collaborations

Mookherjee has collaborated with notable colleagues such as Zhijian Wu and Anand Swaroop, contributing to the collective effort in advancing gene therapy research.

Conclusion

Suddhasil Mookherjee's innovative work in gene therapy has the potential to transform the treatment landscape for patients with inherited retinal diseases. His patents reflect a commitment to improving visual function and enhancing the quality of life for those affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…